Report Categories
View AllRecent Articles
View All
CGNT Q1 2026 Earnings EPS Surges Past Estimates by 126 but Stock Slips
Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue
ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds
Silvercrest Asset Management Group Inc Q1 2026 Earnings EPS Misses Estimates Stock Declines
HBANP Q1 2026 Earnings Preferred Dividend Misses Estimates as Net Interest Margin Pressures Persist